The global endocrine testing market size is expected to be worth around USD 12.8 billion by 2032 from USD 5.45 billion in 2022, growing at a CAGR of 8.92% during the forecast period from 2022 to 2032.
Key Takeaways:
- North America has accounted revenue share of around 46% in 2022.
- By End-user, the commercial laboratories segment captured more than 49% of revenue share in 2022.
- The hospital end-user segment has captured a revenue share of 35% in 2022.
- By Test Type, the human Chorionic Gonadotropin (hCG) hormone test segment dominated the market in 2022, the segment is expected to continue the trend during the forecast period.
- By Technology, the immunoassay segment dominated the market in 2022.
Report Summary
The latest released research study on Global Printed and Endocrine testing Market, offers a detailed overview of the factors influencing the global business scope. The Printed and Endocrine testing Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Printed and Endocrine testing Market. The study also provides information on past and current market trends and developments, factors, capacities, technologies, and changes in market capital structure Printed and Endocrine testing Market. The study will assist market participants and market consultants to understand the continuing structure of the Printed and Endocrine testing Market. Our analysts monitoring the situation across the globe explain that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3211
The report endeavors to offer a 360-degree analysis of the global Printed and Endocrine testing Market on the back of an insightful study of the prevailing demand and supply trends, important fiscal statistics of major players sustaining in the market, and the influence of latest economic advancements on the market. Developments in each geographical region is charted using authentic historical data with a view to help gauge the future trajectory of the market across the globe. SWOT analysis is conducted to identify the strengths, weaknesses, opportunities, and threats that these companies forecast to witness during the forecast period.
Report Scope of the Endocrine Testing Market:
| Report Coverage | Details |
| Market Size in 2023 | USD 5.93 Billion |
| Market Size by 2032 | USD 12.8 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 8.92% |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Test Type, By Technology, and By End-User |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Read More: Point-of-Care Medical Imaging Market Size to Worth USD 5.9 Billion By 2032
Market Size Estimation
Based on the provided information, it seems that the data you have is sourced from Precedence Research Reports. They have used both top-down and bottom-up approaches to estimate and validate the global market size for various parameters such as company, regional division, product type, and application (end users).
The endocrine testing market size estimations in the report are based on the selling price, excluding any discounts offered by manufacturers, distributors, wholesalers, or traders. The market share analysis for each segment and region is determined using the product utilization rate and average selling price.
To determine the revenues, percentage splits, market shares, growth rates, and breakdowns of the product markets for major manufacturers, the report relies on secondary sources and verifies the information through primary sources.
Major companies operating in this area
- Abbott Laboratories
- bioMerieux SA
- Bio-Rad Laboratories Inc.
- DiaSorin S.p.A.
- F. Hoffmann-La Roche Ltd.
- AB Sciex
- Agilent Technologies Inc.
- Ortho Clinical Diagnostics
- Laboratory Corporation of America Holdings
- Quest Diagnostics Incorporated
Endocrine Testing Market Segmentation
By Test Type
- Estradiol (E2) Test
- Dehydroepiandrosterone Sulfate (DHEAS) Test
- Progesterone Test
- Testosterone Test
- Thyroid Stimulating Hormone (TSH) Test
- Prolactin Test
- Follicle Stimulating Hormone (FSH) Test
- Human Chorionic Gonadotropin (hCG) Hormone Test
- Luteinizing Hormone (LH) Test
- Cortisol Test
- Insulin Test
- Others
By Technology
- Immunoassay
- Chromatography
- Mass Spectroscopy
- Nucleic Acid Based
By End-User
- Hospitals
- Commercial Laboratories
- Ambulatory Care Centers
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies.
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions, and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops the Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Endocrine Testing Market
5.1. COVID-19 Landscape: Endocrine Testing Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Endocrine Testing Market, By Test Type
8.1. Endocrine Testing Market, by Test Type, 2023-2032
8.1.1 Estradiol (E2) Test
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Dehydroepiandrosterone Sulfate (DHEAS) Test
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Progesterone Test
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Testosterone Test
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Thyroid Stimulating Hormone (TSH) Test
8.1.5.1. Market Revenue and Forecast (2020-2032)
8.1.6. Prolactin Test
8.1.6.1. Market Revenue and Forecast (2020-2032)
8.1.7. Follicle Stimulating Hormone (FSH) Test
8.1.7.1. Market Revenue and Forecast (2020-2032)
8.1.8. Human Chorionic Gonadotropin (hCG) Hormone Test
8.1.8.1. Market Revenue and Forecast (2020-2032)
8.1.9. Luteinizing Hormone (LH) Test
8.1.9.1. Market Revenue and Forecast (2020-2032)
8.1.10. Cortisol Test
8.1.10.1. Market Revenue and Forecast (2020-2032)
8.1.11. Insulin Test
8.1.11.1. Market Revenue and Forecast (2020-2032)
8.1.12. Others
8.1.12.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Endocrine Testing Market, By Technology
9.1. Endocrine Testing Market, by Technology, 2023-2032
9.1.1. Immunoassay
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Chromatography
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Mass Spectroscopy
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Nucleic Acid Based
9.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Endocrine Testing Market, By End-User
10.1. Endocrine Testing Market, by End-User, 2023-2032
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Commercial Laboratories
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Ambulatory Care Centers
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Endocrine Testing Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.1.2. Market Revenue and Forecast, by Technology (2020-2032)
11.1.3. Market Revenue and Forecast, by End-User (2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.1.4.2. Market Revenue and Forecast, by Technology (2020-2032)
11.1.4.3. Market Revenue and Forecast, by End-User (2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.1.5.2. Market Revenue and Forecast, by Technology (2020-2032)
11.1.5.3. Market Revenue and Forecast, by End-User (2020-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.2.2. Market Revenue and Forecast, by Technology (2020-2032)
11.2.3. Market Revenue and Forecast, by End-User (2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.2.4.2. Market Revenue and Forecast, by Technology (2020-2032)
11.2.4.3. Market Revenue and Forecast, by End-User (2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.2.5.2. Market Revenue and Forecast, by Technology (2020-2032)
11.2.5.3. Market Revenue and Forecast, by End-User (2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.2.6.2. Market Revenue and Forecast, by Technology (2020-2032)
11.2.6.3. Market Revenue and Forecast, by End-User (2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.2.7.2. Market Revenue and Forecast, by Technology (2020-2032)
11.2.7.3. Market Revenue and Forecast, by End-User (2020-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.3.2. Market Revenue and Forecast, by Technology (2020-2032)
11.3.3. Market Revenue and Forecast, by End-User (2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.3.4.2. Market Revenue and Forecast, by Technology (2020-2032)
11.3.4.3. Market Revenue and Forecast, by End-User (2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.3.5.2. Market Revenue and Forecast, by Technology (2020-2032)
11.3.5.3. Market Revenue and Forecast, by End-User (2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.3.6.2. Market Revenue and Forecast, by Technology (2020-2032)
11.3.6.3. Market Revenue and Forecast, by End-User (2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.3.7.2. Market Revenue and Forecast, by Technology (2020-2032)
11.3.7.3. Market Revenue and Forecast, by End-User (2020-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.4.2. Market Revenue and Forecast, by Technology (2020-2032)
11.4.3. Market Revenue and Forecast, by End-User (2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.4.4.2. Market Revenue and Forecast, by Technology (2020-2032)
11.4.4.3. Market Revenue and Forecast, by End-User (2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.4.5.2. Market Revenue and Forecast, by Technology (2020-2032)
11.4.5.3. Market Revenue and Forecast, by End-User (2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.4.6.2. Market Revenue and Forecast, by Technology (2020-2032)
11.4.6.3. Market Revenue and Forecast, by End-User (2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.4.7.2. Market Revenue and Forecast, by Technology (2020-2032)
11.4.7.3. Market Revenue and Forecast, by End-User (2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.5.2. Market Revenue and Forecast, by Technology (2020-2032)
11.5.3. Market Revenue and Forecast, by End-User (2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.5.4.2. Market Revenue and Forecast, by Technology (2020-2032)
11.5.4.3. Market Revenue and Forecast, by End-User (2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
11.5.5.2. Market Revenue and Forecast, by Technology (2020-2032)
11.5.5.3. Market Revenue and Forecast, by End-User (2020-2032)
Chapter 12. Company Profiles
12.1. Abbott Laboratories
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. bioMerieux SA
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Bio-Rad Laboratories Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. DiaSorin S.p.A.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. F. Hoffmann-La Roche Ltd.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. AB Sciex
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Agilent Technologies Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Ortho Clinical Diagnostics
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Laboratory Corporation of America Holdings
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Quest Diagnostics Incorporated
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
